Entera Bio (NASDAQ:ENTX) Earns Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Entera Bio (NASDAQ:ENTX – Free Report) in a research note issued to investors on Monday, Benzinga reports. They currently have a $10.00 price objective on the stock. HC Wainwright also issued estimates for Entera Bio’s Q3 2023 earnings at ($0.09) EPS, Q4 2023 earnings at ($0.08) […]